rs545214029
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_206965.2(FTCD):āc.1166C>Gā(p.Thr389Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,550,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_206965.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTCD | NM_206965.2 | c.1166C>G | p.Thr389Arg | missense_variant | 10/14 | ENST00000397746.8 | NP_996848.1 | |
FTCD | NM_001320412.2 | c.1166C>G | p.Thr389Arg | missense_variant | 10/15 | NP_001307341.1 | ||
FTCD | NM_006657.3 | c.1166C>G | p.Thr389Arg | missense_variant | 10/15 | NP_006648.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTCD | ENST00000397746.8 | c.1166C>G | p.Thr389Arg | missense_variant | 10/14 | 1 | NM_206965.2 | ENSP00000380854 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152040Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000196 AC: 3AN: 152710Hom.: 0 AF XY: 0.0000245 AC XY: 2AN XY: 81552
GnomAD4 exome AF: 0.0000100 AC: 14AN: 1398664Hom.: 0 Cov.: 32 AF XY: 0.0000159 AC XY: 11AN XY: 690226
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74394
ClinVar
Submissions by phenotype
Glutamate formiminotransferase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 340424). This variant has not been reported in the literature in individuals affected with FTCD-related conditions. This variant is present in population databases (rs545214029, gnomAD 0.008%). This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 389 of the FTCD protein (p.Thr389Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at